Treatment with antidepressant medications in private health plans

被引:18
|
作者
Larson, Mary Jo
Miller, Kay
Fleming, Kathleen J.
机构
[1] New England Res Inst Inc, Inst Hlth Serv Res, Watertown, MA 02472 USA
[2] Medstat, Santa Barbara, CA 93111 USA
[3] New England Res Inst Inc, Watertown, MA USA
关键词
antidepressants; utilization; expenditures; private insurance;
D O I
10.1007/s10488-006-0088-5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This study analyzed 2002 MarketScan data from a convenience sample of enrollees with private health insurance from the largest U.S. firms to examine utilization, expenditures, and factors associated with antidepressant prescriptions. Of enrollees, 11% received at least one antidepressant prescription during the year with average expenditures per enrollee of $51.55. Antidepressant prescriptions were more frequently used than any form of other mental health care and for 42% of users was not associated with any clearly identified mental health or "off-label" indication. In logistical regression analyses, health plan type, prescription days supply, gender, region, age, employment status, and subscriber status were associated with unexplained antidepressant prescription use.
引用
收藏
页码:116 / 126
页数:11
相关论文
共 50 条
  • [21] Antidepressant Medications, Placebo, and the Use of Hypnosis in the Treatment of Depression
    Frischholz, Edward J.
    AMERICAN JOURNAL OF CLINICAL HYPNOSIS, 2012, 55 (03) : 209 - 214
  • [22] Treatment of depression with antidepressant medications in patients with cardiovascular disease
    Kapfhammer, HP
    Rothenhäusler, HB
    PHARMACOPSYCHIATRY, 2003, 36 (05) : 238 - 239
  • [23] Access to Addiction Pharmacotherapy in Private Health Plans
    Reif, Sharon
    Horgan, C. M.
    Garnick, D. W.
    Merrick, E. L.
    Hodgkin, D.
    Stewart, M. T.
    Quinn, A. E.
    SUBSTANCE ABUSE, 2013, 34 (02) : 209 - 210
  • [24] Access to Addiction Pharmacotherapy in Private Health Plans
    Reif, Sharon
    Horgan, Constance M.
    Hodgkin, Dominic
    Matteucci, Ann-Marie
    Creedon, Timothy B.
    Stewart, Maureen T.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2016, 66 : 23 - 29
  • [25] ACCESS TO ADDICTION PHARMACOTHERAPY IN PRIVATE HEALTH PLANS
    Reif, S.
    Horgan, C.
    Garnick, D.
    Hodgkin, D.
    Merrick, E.
    Quinn, A.
    Stewart, M.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 : 169A - 169A
  • [26] How Do Private Health Plans Manage Specialty Behavioral Health Treatment Entry and Continuing Care?
    Quinn, Amity E.
    Reif, Sharon
    Merrick, Elizabeth L.
    Horgan, Constance M.
    Garnick, Deborah W.
    Stewart, Maureen T.
    PSYCHIATRIC SERVICES, 2017, 68 (09) : 931 - 937
  • [27] A framework for describing the impact of antidepressant medications on population health status
    Patten, SB
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2002, 11 (07) : 549 - 559
  • [28] Benefit Limits for Behavioral Health Care in Private Health Plans
    Dominic Hodgkin
    Constance M. Horgan
    Deborah W. Garnick
    Elizabeth L. Merrick
    Administration and Policy in Mental Health and Mental Health Services Research, 2009, 36 : 15 - 23
  • [29] Management of Behavioral Health Provider Networks in Private Health Plans
    Garnick, Deborah W.
    Horgan, Constance M.
    Reif, Sharon
    Merrick, Elizabeth L.
    Hodgkin, Dominic
    JOURNAL OF AMBULATORY CARE MANAGEMENT, 2008, 31 (04): : 330 - 341
  • [30] Benefit Limits for Behavioral Health Care in Private Health Plans
    Hodgkin, Dominic
    Horgan, Constance M.
    Garnick, Deborah W.
    Merrick, Elizabeth L.
    ADMINISTRATION AND POLICY IN MENTAL HEALTH AND MENTAL HEALTH SERVICES RESEARCH, 2009, 36 (01) : 15 - 23